CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. [electronic resource]

By:

Damkier, Per

Contributor(s):

Kjærsgaard, Anders
Barker, Kimberly A
Cronin-Fenton, Deidre
Crawford, Anatasha
Hellberg, Ylva
Janssen, Emilius A M
Langefeld, Carl
Ahern, Thomas P
Lash, Timothy L

Producer: 20190225Description: 7727 p. digitalISSN:

2045-2322

Subject(s):

Alleles
Antineoplastic Agents, Hormonal -- pharmacology
Biomarkers, Tumor
Breast Neoplasms -- drug therapy
Cytochrome P-450 CYP2C19 -- genetics
Female
Genetic Variation
Genotype
Humans
Neoplasm Recurrence, Local
Pharmacogenetics
Prognosis
Proportional Hazards Models
Tamoxifen -- pharmacology

Online resources:

Available from publisher's website

In: Scientific reports vol. 7

Tags from this library: No tags from this library for this title. Log in to add tags.

Star ratings

Cancel rating. Average rating: 0.0 (0 votes)

Holdings ( 0 )
Title notes ( 1 )
Comments ( 0 )

No physical items for this record

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

There are no comments on this title.

CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset.

APA

Damkier P., Kjærsgaard A., Barker K. A., Cronin-Fenton D., Crawford A., Hellberg Y., Janssen E. A. M., Langefeld C., Ahern T. P. & Lash T. L. (20190225). CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. : Scientific reports.

Chicago

Damkier Per, Kjærsgaard Anders, Barker Kimberly A, Cronin-Fenton Deidre, Crawford Anatasha, Hellberg Ylva, Janssen Emilius A M, Langefeld Carl, Ahern Thomas P and Lash Timothy L. 20190225. CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. : Scientific reports.

Harvard

Damkier P., Kjærsgaard A., Barker K. A., Cronin-Fenton D., Crawford A., Hellberg Y., Janssen E. A. M., Langefeld C., Ahern T. P. and Lash T. L. (20190225). CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. : Scientific reports.

MLA

Damkier Per, Kjærsgaard Anders, Barker Kimberly A, Cronin-Fenton Deidre, Crawford Anatasha, Hellberg Ylva, Janssen Emilius A M, Langefeld Carl, Ahern Thomas P and Lash Timothy L. CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. : Scientific reports. 20190225.

Print
Cite
Add to your cart (remove)
Save record
BIBTEX Dublin Core MARCXML MARC (non-Unicode/MARC-8) MARC (Unicode/UTF-8) MARC (Unicode/UTF-8, Standard) MODS (XML) RIS ISBD
More searches

Search for this title in:
Other Libraries (WorldCat) Other Databases (Google Scholar) Online Stores (Bookfinder.com) Open Library (openlibrary.org)

Exporting to Dublin Core...

Simple DC-RDF

OAI-DC

SRW-DC

CYP2C19*2 and CYP2C19*17 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. [electronic resource]

CYP2C192 and CYP2C1917 variants and effect of tamoxifen on breast cancer recurrence: Analysis of the International Tamoxifen Pharmacogenomics Consortium dataset. [electronic resource]